Form S-3 Bone Biologics Corp For: 17 July
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Bone Biologics Corp (BBLG)
Bone Biologics Corp stock price live, this page displays NASDAQ BBLG stock exchange data. View the BBLG premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Bone Biologics Corp real time stock price chart below.
What Is the Bone Biologics Corp Stock Price Today?
The Bone Biologics Corp stock price today is 0.6123.
What Is the Stock Symbol for Bone Biologics Corp?
The stock symbol for Bone Biologics Corp is "BBLG."
What Stock Exchange Does Bone Biologics Corp Trade On?
Bone Biologics Corp is listed and trades on the NASDAQ stock exchange.
Is Bone Biologics Corp a Good Stock to Buy?
Determining whether Bone Biologics Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BBLG quote. (ISIN: US0980706008)
What Is the Bone Biologics Corp Stock Price Today?
The Bone Biologics Corp stock price today is 0.6123.
What Is the Stock Symbol for Bone Biologics Corp?
The stock symbol for Bone Biologics Corp is "BBLG."
What Stock Exchange Does Bone Biologics Corp Trade On?
Bone Biologics Corp is listed and trades on the NASDAQ stock exchange.
Is Bone Biologics Corp a Good Stock to Buy?
Determining whether Bone Biologics Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BBLG quote. (ISIN: US0980706008)
0.6123
-0.0310(-4.82%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.6121
0.6300
52 wk Range
0.6050
4.1299
Earnings results expected in 14 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.61210.6300
52 wk Range
0.60504.1299
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
BBLG Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in oversold territory
Form 8K Bone Biologics Corp For: 13 March- Investing.com
Form DEF 14A BONE BIOLOGICS CORPORATION For: 2 July- Investing.com
Form 424B5 Bone Biologics Corp For: 13 March- Investing.com
- Form S-3 Bone Biologics Corp For: 17 July
- Investing.com
- Form DEF 14A BONE BIOLOGICS CORPORATION For: 2 July
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Earnings
Latest Release
Jun 03, 2026
EPS / Forecast
-0.43 / --
Revenue / Forecast
-- / --
Compare BBLG to Peers and Sector
Metrics to compare | BBLG | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBBLGPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.4x | −2.7x | −0.3x | |
PEG Ratio | 0.00 | 0.14 | 0.00 | |
Price/Book | 0.3x | 2.1x | 2.6x | |
Price / LTM Sales | - | 7.3x | 3.1x | |
Upside (Analyst Target) | - | 139.9% | 50.4% | |
Fair Value Upside | Unlock | 13.5% | 6.4% | Unlock |
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein in the United States. Its lead product is NELL-1/DBM medical device, an osteopromotive recombinant protein, which provides target specific control over bone regeneration. The company also develops NB1, a NELL-1/DBM fusion device for use in lumbar spinal fusion, as well as spine implants, non-union trauma cases, and osteoporosis applications. It serves spine surgeons and patients with a skeletal bone defect or bone-related condition in their spine. The company has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion by local administration, osteoporosis, and trauma applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Bone Biologics (BBLG) Stock Price Today?
The Bone Biologics stock price today is 0.6123 USD.
What Stock Exchange Does Bone Biologics Trade On?
Bone Biologics is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Bone Biologics?
The stock symbol for Bone Biologics is "BBLG."
What Is the Bone Biologics Market Cap?
As of today, Bone Biologics market cap is 1.1300M USD.
What Is Bone Biologics's Earnings Per Share (TTM)?
The Bone Biologics EPS (TTM) is -1.6080.
When Is the Next Bone Biologics Earnings Date?
Bone Biologics will release its next earnings report on Sep 02, 2026.
From a Technical Analysis Perspective, Is BBLG a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Bone Biologics Stock Split?
Bone Biologics has split 5 times.
How Many Employees Does Bone Biologics Have?
Bone Biologics has 2 employees.
What is the current trading status of Bone Biologics (BBLG)?
As of Aug 19, 2026, Bone Biologics (BBLG) is trading at a price of 0.6123 USD, with a previous close of 0.6433 USD. The stock has fluctuated within a day range of 0.6121 USD to 0.6300 USD, while its 52-week range spans from 0.6050 USD to 4.1299 USD.
What Is Bone Biologics (BBLG) Price Target According to Analysts?
The average 12-month price target for Bone Biologics is 12.2000 USD, with a high estimate of 12.2 USD and a low estimate of 12.2 USD. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +1,892.49% Upside potential.
What Is the BBLG Premarket Price?
BBLG's last pre-market stock price is 0.6390 USD. The pre-market share volume is 22,440.0000, and the stock has decreased by -0.0043, or -0.6700%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.